Dividends Calendar Earnings Calendar
KOD

KOD | Kodiak Sciences Inc

Healthcare sector
Kodiak Sciences Inc
  • Industry: Biotechnology

Quick infos

    Trade prices

    • Volume:
    • Market Cap: 402.64M
    • Prev closed:
    • Open:
    • High:
    • Low:
    • 52 week low:
    • 52 week high:
    • Dividends:No Dividends

    Next ER: April 4, 2023  After Market Closes



    Top Stories (KOD)

      Company Profile

      Kodiak Sciences Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing therapeutics to treat ophthalmic diseases.

      Earnings History

      Date EPS / Forecast Revenue / Forecast
      May 16, 2023- / -1.44- / -
      March 28, 2023-1.35 / -1.48- / -
      February 28, 2023- / -1.72- / -
      November 16, 2022- / -1.69- / -
      August 9, 2022-1.74 / -1.7- / -
      view more


      NASDAQ - Nasdaq Stock Market

      More profiles and info about the company

      • Employees:101

      News

      News for (KOD)

      This company doesn't provide a dividend.


      Talk about Kodiak Sciences Inc below in comments section below.

      Do you think you'll buy? Do you already have active trades now?

      EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
      This profile is based on publicly available information and is intended to be informative in nature.

      Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




      Other ER on Apr 4, 2023 (Same day)

      ayi msm 


      Jump to (Finance sites)

      Google   
               

      Research 

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      Investing For Dummies
      Buy on Amazon

      In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.